Popular

Pediatric Flu Vaccines: Evidence, Guidelines, and Communication
VacciNationPediatric Flu Vaccines: Evidence, Guidelines, and Communication

INFINITY in Focus: Translating New Nonsteroidal MRA Evidence Into Cardiorenal Practice
NephrologyINFINITY in Focus: Translating New Nonsteroidal MRA Evidence Into Cardiorenal Practice

Real-World Evidence: Effectiveness of Finerenone in Reducing UACR in Patients With CKD and Type 2 Diabetes
Diabetes and EndocrinologyReal-World Evidence: Effectiveness of Finerenone in Reducing UACR in Patients With CKD and Type 2 Diabetes

FINE-ONE Across the Ages: Evaluating nsMRA Evidence in CKD and Type 1 Diabetes
Diabetes and EndocrinologyFINE-ONE Across the Ages: Evaluating nsMRA Evidence in CKD and Type 1 Diabetes

Starting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
CME/CEStarting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
Programs

FINE-ONE Across the Ages: Evaluating nsMRA Evidence in CKD and Type 1 Diabetes
Diabetes and EndocrinologyFINE-ONE Across the Ages: Evaluating nsMRA Evidence in CKD and Type 1 Diabetes

Personalized CRC Screening: Applying Real-World Evidence to Test Selection
Clinician's RoundtablePersonalized CRC Screening: Applying Real-World Evidence to Test Selection

Secondary Stroke Prevention in Focus: Addressing Residual Thrombotic Risk
CME/CE Broadcast ReplaySecondary Stroke Prevention in Focus: Addressing Residual Thrombotic Risk

Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
CME/CEReimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy

Potential Impact of Aryl Hydrocarbon Activation on Pigment
Practical DermatologyPotential Impact of Aryl Hydrocarbon Activation on Pigment
Clinical Practice

INFINITY in Focus: Translating New Nonsteroidal MRA Evidence Into Cardiorenal Practice
NephrologyINFINITY in Focus: Translating New Nonsteroidal MRA Evidence Into Cardiorenal Practice

When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
CME/CE Broadcast ReplayWhen “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease

The Next Generation of Care: New Treatment Frontiers in Immunotherapy-Resistant Advanced Squamous NSCLC
CME/CEThe Next Generation of Care: New Treatment Frontiers in Immunotherapy-Resistant Advanced Squamous NSCLC

Navigating the Limitations of Current BD Therapies
MinuteCE®Navigating the Limitations of Current BD Therapies

Sticking Points: Managing Injection Site Reactions From Long-Acting Injectable Medications for HIV Care
CME/CESticking Points: Managing Injection Site Reactions From Long-Acting Injectable Medications for HIV Care
Doctors Lounge

Humanoids in Healthcare: Extending the Reach of Surgical Expertise
The ConvergenceHumanoids in Healthcare: Extending the Reach of Surgical Expertise

The Science of Exceptions: Setting the Safety Bar for Clinical AI
The ConvergenceThe Science of Exceptions: Setting the Safety Bar for Clinical AI

“We have the opportunity to understand what happens when someone leaves the clinic,” says Dr. Rajiv Kumar of Apple and Stanford Medicine
The Convergence“We have the opportunity to understand what happens when someone leaves the clinic,” says Dr. Rajiv Kumar of Apple and Stanford Medicine
CME

Translating Evidence Into Practice: Myosin Inhibition Across the HCM Spectrum
CME/CETranslating Evidence Into Practice: Myosin Inhibition Across the HCM Spectrum

LGMD in Focus: Early Diagnosis, Precision Subtyping, and Targeted Therapies
CME/CELGMD in Focus: Early Diagnosis, Precision Subtyping, and Targeted Therapies

Moving the Needle in oHCM: The Era of Cardiac Myosin Inhibitors
CME/CEMoving the Needle in oHCM: The Era of Cardiac Myosin Inhibitors

The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
MinuteCE®The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
CME/CE In-Person & Virtual EventSpotlight on B7-H3 ES-SCLC: Applying ADC Evidence in Real-World Practice
December 5, 2026
Scottsdale, Arizona
Industry Feature

Helping Patients Stay on Track With Collaborative LDL-C Care
Medical Industry FeatureHelping Patients Stay on Track With Collaborative LDL-C Care

Taking Action in Friedreich Ataxia From Diagnosis to Treatment
Medical Industry FeatureTaking Action in Friedreich Ataxia From Diagnosis to Treatment

A Real-World CIDP Patient Journey: Perspectives From a Neuromuscular Specialist
Medical Industry FeatureA Real-World CIDP Patient Journey: Perspectives From a Neuromuscular Specialist

Guiding Long-Term Care in Friedreich Ataxia
Medical Industry FeatureGuiding Long-Term Care in Friedreich Ataxia

Unraveling PMR Pathophysiology: The Central Role of IL-6
Medical Industry FeatureUnraveling PMR Pathophysiology: The Central Role of IL-6
























































































































